Tissue Regenix Group plc's (LON:TRX) Share Price Is Matching Sentiment Around Its Revenues
Jun 01
U.K. (FTSE) Biotech Industry Analysis
UpdatedJun 03, 2024
DataAggregated Company Financials
Companies25
- 7D-0.7%
- 3M11.0%
- 1Y-21.0%
- YTD-9.0%
The Biotech industry has stayed flat over the last week. As for the longer term, the industry has declined 21% in the last year. Earnings are forecast to grow by 28% annually.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 03 Jun 2024 | UK£3.0b | UK£836.3m | -UK£287,266,028.40 | 30.6x | -10.3x | 3.6x |
| Wed, 01 May 2024 | UK£3.2b | UK£873.6m | -UK£294,449,404.28 | 31.7x | -10.8x | 3.7x |
| Fri, 29 Mar 2024 | UK£3.1b | UK£903.1m | -UK£202,194,058.72 | 28.5x | -15.2x | 3.4x |
| Sun, 25 Feb 2024 | UK£3.3b | UK£896.7m | -UK£197,698,774.85 | 32.6x | -16.7x | 3.7x |
| Tue, 23 Jan 2024 | UK£6.4b | UK£1.3b | -UK£245,270,537.00 | 37.1x | -25.9x | 5x |
| Thu, 21 Dec 2023 | UK£6.3b | UK£1.3b | -UK£245,477,603.00 | 38.3x | -25.5x | 4.9x |
| Sat, 18 Nov 2023 | UK£6.4b | UK£1.3b | -UK£246,613,641.00 | 38.6x | -25.9x | 5x |
| Mon, 16 Oct 2023 | UK£6.6b | UK£1.3b | -UK£251,303,385.00 | 38.4x | -26.1x | 5.1x |
| Wed, 13 Sep 2023 | UK£6.6b | UK£1.3b | -UK£206,920,959.00 | 23.4x | -31.8x | 5.1x |
| Fri, 11 Aug 2023 | UK£6.8b | UK£1.3b | -UK£207,924,120.00 | 23.6x | -32.6x | 5.4x |
| Sun, 09 Jul 2023 | UK£6.7b | UK£1.3b | -UK£208,544,050.00 | 23.9x | -32.2x | 5.3x |
| Tue, 06 Jun 2023 | UK£7.0b | UK£1.3b | -UK£205,615,201.00 | 22.9x | -34x | 5.5x |
| Thu, 04 May 2023 | UK£7.0b | UK£1.3b | -UK£206,075,442.00 | 23.9x | -34.1x | 5.6x |
| Sat, 01 Apr 2023 | UK£7.2b | UK£1.2b | -UK£154,258,301.00 | 24.3x | -46.5x | 5.8x |
| Mon, 27 Feb 2023 | UK£7.4b | UK£1.2b | -UK£156,977,013.00 | 26.1x | -47.4x | 6x |
| Wed, 25 Jan 2023 | UK£7.6b | UK£1.2b | -UK£140,260,963.00 | 27.6x | -54.5x | 6.6x |
| Fri, 23 Dec 2022 | UK£7.4b | UK£1.2b | -UK£138,509,681.00 | 27.2x | -53.8x | 6.4x |
| Sun, 20 Nov 2022 | UK£7.8b | UK£1.2b | -UK£139,984,413.00 | 25.1x | -55.6x | 6.7x |
| Tue, 18 Oct 2022 | UK£7.0b | UK£1.2b | -UK£150,681,291.00 | 26.2x | -46.7x | 6.1x |
| Thu, 15 Sep 2022 | UK£7.6b | UK£1.2b | -UK£143,095,207.00 | 34.6x | -53.1x | 6.5x |
| Sat, 13 Aug 2022 | UK£7.5b | UK£1.1b | -UK£200,888,849.00 | 38x | -37.4x | 6.7x |
| Mon, 11 Jul 2022 | UK£7.1b | UK£1.1b | -UK£175,037,886.00 | 36.3x | -40.4x | 6.3x |
| Wed, 08 Jun 2022 | UK£7.1b | UK£1.1b | -UK£156,413,377.00 | 37.5x | -45.3x | 6.4x |
| Fri, 06 May 2022 | UK£7.1b | UK£1.1b | -UK£144,650,681.00 | 34.5x | -49x | 6.4x |
| Sun, 03 Apr 2022 | UK£7.4b | UK£1.1b | -UK£87,748,275.00 | 41.5x | -83.9x | 6.7x |
| Tue, 01 Mar 2022 | UK£7.9b | UK£1.1b | -UK£130,171,176.00 | 34.8x | -60.5x | 7.3x |
| Thu, 27 Jan 2022 | UK£9.0b | UK£1.1b | -UK£125,499,750.00 | 41.6x | -71.5x | 8.3x |
| Sat, 25 Dec 2021 | UK£11.4b | UK£1.1b | -UK£120,910,006.00 | 55.9x | -93.9x | 10.5x |
| Mon, 22 Nov 2021 | UK£11.9b | UK£1.1b | -UK£150,400,787.00 | 65.9x | -79.2x | 11x |
| Wed, 20 Oct 2021 | UK£12.2b | UK£1.1b | -UK£148,296,619.00 | 70.3x | -82x | 11x |
| Fri, 17 Sep 2021 | UK£12.3b | UK£1.0b | -UK£164,865,395.00 | 53.5x | -74.9x | 11.8x |
| Sun, 15 Aug 2021 | UK£12.3b | UK£1.0b | -UK£172,541,949.91 | 29.7x | -71.4x | 12.1x |
| Thu, 10 Jun 2021 | UK£11.4b | UK£1.0b | -UK£166,338,934.52 | 30.7x | -68.3x | 11.2x |
Price to Earnings Ratio
-68.3x
Current Industry PE
- Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 7.2x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 6.3% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -0.56% | |
| Healthcare | -0.64% | |
| Biotech | -0.65% | |
| Biotech | -0.65% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PRTC PureTech Health | UK£2.34 | 2.9% +UK£17.6m | -0.2% | PS242.5x | |
| TRX Tissue Regenix Group | UK£0.69 | 11.3% +UK£4.9m | 35.3% | PS2.1x | |
| OXB Oxford Biomedica | UK£3.31 | 1.2% +UK£4.0m | -28.4% | PS3.7x | |
| GENF Genflow Biosciences | UK£0.03 | 13.0% +UK£1.2m | 27.1% | PB14.7x | |
| PBX ProBiotix Health | UK£0.05 | 17.6% +UK£912.5k | 0% | PS3.9x |